Wikipedia -WSS

Wikipedia

author：explore 2025-08-26 10:55:30 - browse：55

MODERNA - Norwood facility — Alex Hogan/STAT

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

“We’re excited to move forward in our discussions with regulators, and hopefully continue to help address respiratory viruses globally,” Moderna President Stephen Hoge told STAT in an interview in which he acknowledged that the fall 2025 vaccine rollout is a target the company would like to hit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

entertainment

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

Gene therapy has helped boys walk. Can scientists keep it that way?

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Judge sides with young activists in first

Health AI: on the border between health care and tech

Patients, digital health players weigh in on FTC's data privacy plan

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Psychedelics group wrestles with new pharma identity

Senators push IRS to launch nonprofit hospital probe

Activists slam private health insurers over coverage restrictions

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Bright Health sells Medicare Advantage business to Molina

Megan Rapinoe shares emotional post following US Women's World Cup exit

ChatGPT in medicine: STAT answers readers' burning questions

Timeline: How the deadly wildfires took over Maui day by day

DIEP, the 'gold standard' of breast reconstruction, is under threat

Surge in Apellis stock fueled by confidence in safety of its eye drug

knowledge

Why are elite athletes different? Take a look at their microbes

BMS, looking to build heart drug business, turns to AI for diagnosis

Timeline: How the deadly wildfires took over Maui day by day

Disclosing genetic information: not as worrisome as once feared

The science behind Janet Jackson's pregnancy at 49

Why are elite athletes different? Take a look at their microbes

Wikipedia

hotspot

entertainment

leisure time